A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia
Clinical trial NCT00210548 · COMPLETED
Trial details
- NCT number
- NCT00210548
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.